Shattuck Labs, Inc. - Common Stock (NQ:STTK)

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% to 36,789.77 while the NASDAQ rose 0.63% to 14,624.74....

Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady ↗

December 13, 2023

Via Benzinga

Topics Economy Stocks

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 13, 2023

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700...

Via Benzinga

Recap: Shattuck Labs Q3 Earnings ↗

November 09, 2023

Via Benzinga

Earnings Outlook For Shattuck Labs ↗

November 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 13, 2023

Via Benzinga

Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet ↗

December 13, 2023

U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 36,598.24 while the NASDAQ rose 0.23% to 14,566.43. The S&P 500 also rose,...

Via Benzinga

Topics Stocks

Shattuck Labs Inc. (NASDAQ: STTK) is One of Wednesday Morning’s Most Active Stocks

December 13, 2023

Via Investor Brand Network

EY Layoffs 2023: What to Know About the Latest EY Job Cuts ↗

December 13, 2023

EY layoffs have been announced and this has the accounting firm cutting 130 jobs to adjust for slowing demand after the pandemic.

Shattuck Labs stock is rising on Wednesday after the company provided positive initial results from a Phase 1 clinical trial.

Topics Workforce

Why Is Shattuck Labs (STTK) Stock Up 93% Today? ↗

December 13, 2023

Shattuck Labs Inc (NASDAQ: STTK) announced initial topline dose-expansion data from its ongoing Phase 1A/B trial of SL-172154 in combination with Azacitidine (AZA) in frontline high-risk...

Shattuck Labs: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Why Is Blood Cancer-Focused Shattuck Labs Stock Soaring Today? ↗

December 13, 2023

Via Benzinga

US Stocks Mixed; Producer Prices Unchanged For November ↗

December 13, 2023

U.S. stocks traded mixed this morning, following the release of PPI data on Wednesday. Following the market opening Wednesday, the Dow traded down 0.05% to 36,561.18 while the NASDAQ rose 0.42% to...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 13, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

December 13, 2023

Pre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching!

Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML)

December 13, 2023

Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation

December 05, 2023

Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference

November 14, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

Earnings Scheduled For November 9, 2023 ↗

November 09, 2023

Via Benzinga

Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights

November 09, 2023

Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023

November 06, 2023

Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients at the American Society of Hematology (ASH) 2023

November 02, 2023

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis

October 23, 2023

Via ACCESSWIRE

September 25, 2023

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Via Benzinga

Why Biophytis Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket ↗

September 25, 2023

Gainers FaZe Holdings Inc. (NASDAQ: FAZE) shares rose 64.7% to $0.2520 in pre-market trading after falling over 4% on Friday.

Via Benzinga

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 22, 2023

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 22, 2023

Via Benzinga

Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights

August 10, 2023

Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

May 25, 2023

Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights

May 09, 2023